Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase I Study of Dendritic Cell Vaccine Therapy With In Situ Maturation for Pediatric Brain Tumors

NCT01902771 is registered in ClinicalTrials.gov with Edward Ziga as lead sponsor.

NCT NCT01902771
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01902771 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase I Study of Dendritic Cell Vaccine Therapy With In Situ Maturation for Pediatric Brain Tumors
Lead sponsor
Edward Ziga
Phase
Phase 1
Overall status
Terminated
Start date
September 3, 2013
Completion date
January 26, 2017
Enrollment
1 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

brain cancer, brain tumor, glioblastoma multiforme, glioma, high grade glioma